β-Naphthoflavone induced CYP1A1 and 1A3 proteins in the liver of rainbow trout (Oncorhynchus mykiss)

References

• BERNDTSON, A. K. and CHEN, T. T., 1994, Two unique CYP1 genes are expressed in response to 3-methylcholanthr ene treatment in rainbow trout. Archives of Biochemistry and Biophysics, 310, 187–195.
   PubMed Web of Science ®Google Scholar
• BUHLER, D. R., YANG, Y.-H., DREHER, T. W., MIRANDA, C. L. and WANG, J.-L., 1994, Cloning and sequencing of the major rainbow trout constitutive cytochrome P450 (CYP2K1). Identification of a new cytochrome P450 gene subfamily and its expression in mature rainbow trout and trunk kidney. Archives of Biochemistry and Biophysics, 312, 45–51.
   Google Scholar
• BURNETTE W. N., 1981, Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Analytical Biochemistry, 112, 195–203.
   PubMed Web of Science ®Google Scholar
• CORREIA, M A., 1995, Rat and human liver cytochrome P450: substrate and inhibitor specificities and functional markers. In Cytochrome P450: Structure, Mechanism and Biochemistry 2nd edn, edited by P. R. Ortiz de Montellano (New York: Plenum), pp. 607–627.
   Google Scholar
• CURTIS, L. R., FOSTER, F. P., DA COSTA, E.G., VROLICK, N. and CHEN, T. T., 1996, 2,4,5,2 ',4',5'-Hexachlorobiphe nyl (2HCB) induces rainbow trout hepatic aryl hydrocarbon hydroxylase (AHH) and increases expression of one of two cytochrome P450 (CYP) lA mRNAs. Toxicologist 30, 73.
   Google Scholar
• DEPlERRE, J. W JOHANNESSEN, K. A. M., MORON, M. S. and SEIDEGARD, J., 1978, Radioactive assay of aryl hydrocarbon hydroxylase monooxygenase and epoxide hydrolase. Methods in Enzymology, 52C, 412–418.
   Google Scholar
• GONZALEZ, F. J., VILBOIS, F., H ARDWICK, J. P., MCBRIDE, OW., NEBERT, D. W., GELBOIN, H. V. and M EYER U. A., 1988, Human debrisoquine 4-hydroxylase (P450IID1) : cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22. Genomics, 2, 174–179.
   Google Scholar
• GONZALEZ, F. J. and GELBOIN, H. V., 1994, Roles of cytochrome P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metabolism Reviews, 26, 165–184.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., 1995, Human cytochrome P450 enzymes. In Cytochrome P450: Structure, Mechanism and Biochemistry 2nd edn, edited by P. R. Ortiz de Montellano (New York: Plenum), 473 574
   Google Scholar
• GUENGERICH, F. P. and MARTIN, M. V., 1980, Purification of cytochrome P-450, NADPH- cytochrome P-450 reductase, and epoxide hydratase from a single preparation of rat liver microsomes. Archives of Biochemistry and Biophysics, 205, 365–369.
   PubMed Web of Science ®Google Scholar
• HEILMANN, L. J., SHEEN, Y. Y., BIGELOW, S W. and N EBERT, D. W., 1988, Trout P4501A1 : cDNA and deduced protein sequence, expression in liver, and evolutionary significance. DNA, 7, 379–387.
   PubMedGoogle Scholar
• LAEMMLI, V. K., 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London), 227, 680–685.
   PubMed Web of Science ®Google Scholar
• LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• MATSUDAIRA, P., 1987, Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. Journal of Biological Chemistry, 262, 10035–10038.
   PubMed Web of Science ®Google Scholar
• MIRANDA, C. L., WANG, J.-L., HENDERSON, M. C. and B UHLER, D. R., 1989, Purification and characterization of hepatic steroid hydroxylases from untreated rainbow trout. Archives Biochemistry and Biophysics, 268, 227–238.
   Google Scholar
• MORRISON, H. G., O LEKSIAK, M. F., C ORNELL, N. W., SOGIN, M. L. and STEGEMAN, J. J., 1995, Identification of cytochrome P-450 IA (CYP1A) genes from two teleost fish, toadfish (Opsanus tau) and scup (Stenotomus chrysops), and phylogenetic analysis of CYP1A genes. Biochemical Journal, 308, 97–104.
   PubMed Web of Science ®Google Scholar
• MYERS, C. R., SUTHERLAND, L. A., H AASCH, M. and L ECH, J. J., 1993, Antibodies to a synthetic peptide that react specifically with rainbow trout cytochrome P450 1A1. Environmental Toxicology and Chemistry, 12, 1619–1626.
   Google Scholar
• NEBERT, D. W. and GONZALEZ, F. J., 1987, P450 genes. Structure, evolution and regulation. Annual Review of Biochemistry, 56, 945–993.
   PubMed Web of Science ®Google Scholar
• NELSON D. R., KOYMANS, L., KAMATAKI, T., S TEGEMAN, J. J., FEYEREISEN, R., W AXMAN D. J., W ATERMAN, M. R., GOTOH, O., C OON, M. J., ESTABROOK, R. W., GUNSALUS I. C. and N EBERT, D. W., 1996, P450 superfamily : Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1–42.
   Google Scholar
• NERURKAR, P. V., PARK, S. S., THOMAS, P. E., Nims, R. W. and L UBET R. A., 1993, Methoxyresorufin and benzyloxyresoru fin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse. Biochemical Pharmacology, 46, 933–943.
   Google Scholar
• NEWTON, D. J., WANG, R. W. and Lu, A. Y. H., 1995, Cytochrome P450 inhibitors. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metabolism and Disposition, 23, 154–158.
   PubMed Web of Science ®Google Scholar
• OHTA K., MOTOYA, M., KOMORI, M., M IURA, T., KITADA, M. and KAMATAKI, T., 1989, A novel form of cytochrome P-450 in beagle dogs: P-450-D3 is a low spin form of cytochrome P-450 but with catalytic and structural properties similar to P-450d. Biochemical Pharmacology, 38, 91–96.
   Google Scholar
• OMURA, T. and S ATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370–2378.
   PubMed Web of Science ®Google Scholar
• POHL, R. J. and FOUTS, J. R., 1980, A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Analytical Biochemistry, 107, 150–155.
   PubMed Web of Science ®Google Scholar
• RIFKIND, A. B., K ANETOSHI, A., O RLINICK, J., CAPDEVILA, J. H. and LEE, C., 1994, Purification and biochemical characterization of two major cytochrome P-450 isoforms induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in chick embryo liver. Journal of Biological Chemistry, 269, 3387–3396.
   PubMed Web of Science ®Google Scholar
• SAKAMOTO, K., K IRITA, S., B ABA, T., N AKAMURA, Y., YAMAZOE, Y., K ATO, R., T AKANAKA, A. and M ATSUBARA, T., 1995, A new cytochrome P450 form belonging to the CYP2D in dog liver microsomes : purification, cDNA cloning, and enzyme characterization. Archives of Biochemistry and Biophysics, 319, 372–382.
   PubMed Web of Science ®Google Scholar
• WHITLOCK, JR, J. P., 1993, Mechanistic aspects of dioxin action. Chemical Research in Toxicology, 6, 754–763.
   PubMed Web of Science ®Google Scholar
• WILLIAMS, D. E. and B UHLER, D. R., 1984, Benzo[a]pyrene- hydroxylase catalyzed by purified isozymes of cytochrome P-450 from J3-naphthoflavone-fed rainbow trout. Biochemical Pharmacology, 33, 3743–3753.
   PubMedGoogle Scholar
• XIAODONG, S., G ATTI, G., B ARTOLI, A., C IPOLLA, G., C REMA, F. and PERUCCA, E., 1994, Omeprazo le does not enhance the metabolism of phenacetin, a marker of CYP1A2 activity, in healthy volunteers. Therapeutic Drug Monitoring, 16, 248–250.
   PubMed Web of Science ®Google Scholar